Additional file 3: of Study of serious adverse drug reactions using FDA-approved drug labeling and MedDRA WuLeihong IngleTaylor LiuZhichao Zhao-WongAnna HarrisStephen ThakkarShraddha ZhouGuangxu YangJunshuang XuJoshua MehtaDarshan GeWeigong TongWeida FangHong 2019 Table S3. Enriched cluster among ATC N categories (XLS 40 kb)